Entering text into the input field will update the search result below

Agile Therapeutics, Inc. (AGRX) CEO Alfred Altomari on Q4 2020 Results - Earnings Call Transcript

Mar. 01, 2021 10:45 PM ETAgile Therapeutics, Inc. (AGRX)4 Comments
SA Transcripts profile picture
SA Transcripts

Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2020 Earnings Conference Call March 1, 2021 4:30 PM ET

Company Participants

Matthew Riley - Investor Relations

Alfred Altomari - Chairman, President & Chief Executive Officer

Dennis Reilly - Senior Vice President & Chief Financial Officer

Conference Call Participants

Oren Livnat - H.C. Wainwright

Leland Gershell - Oppenheimer

Lachlan Hanbury-Brown - William Blair & Company


Ladies and gentlemen, thanks for standing by, and welcome to the Agile Therapeutics Fourth Quarter and Full Year 2020 Financial Results Conference Call. At this time all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]

I would now like to turn the conference over to your speaker today, Matt Riley, Head of Investor Relations and Corporate Communications. Thank you. Please, go ahead.

Matthew Riley

Hello, everyone and welcome to today's conference call to discuss our fourth quarter and full year 2020 financial results.

Before we start, let me remind you that today's call will include forward-looking statements based on current expectations, including statements concerning our outlook for the full year 2021, management's expectations for our future financial and operational performance, our business strategy, our assessment of the combined hormonal contraceptive market and the potential market share for Twirla, among other statements regarding our plans, prospects and expectations.

Such statements represent our judgments as of today, are not promises or guarantees and may involve risks and uncertainties that may cause actual results to differ from the results discussed in the forward-looking statements. Please refer to our filings with the SEC, which are available to the Investor Relations section of our website for information concerning risk factors that may affect the company. We undertake no obligation to update forward-looking statements except as required by law. The information on today's call is not intended for promotional purposes

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.